Yandan Yao

9.8k total citations · 3 hit papers
77 papers, 7.1k citations indexed

About

Yandan Yao is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Yandan Yao has authored 77 papers receiving a total of 7.1k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 20 papers in Oncology and 19 papers in Cancer Research. Recurrent topics in Yandan Yao's work include RNA Interference and Gene Delivery (14 papers), Nanoplatforms for cancer theranostics (11 papers) and Nanoparticle-Based Drug Delivery (8 papers). Yandan Yao is often cited by papers focused on RNA Interference and Gene Delivery (14 papers), Nanoplatforms for cancer theranostics (11 papers) and Nanoparticle-Based Drug Delivery (8 papers). Yandan Yao collaborates with scholars based in China, United States and Hong Kong. Yandan Yao's co-authors include Erwei Song, Herui Yao, Bodu Liu, Chang Gong, Qiang Liu, Lijuan Sun, Judy Lieberman, Jun Wang, Songyin Huang and Shunying Li and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Yandan Yao

72 papers receiving 7.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gasdermin E suppresses tumour growth by activating anti-tumour immunity

2020 1.2k citations Yandan Yao, Judy Lieberman et al. profile →
A Cytoplasmic NF-κB Interacting Long Noncoding RNA Blocks IκB Phosphorylation and Suppresses Breast Cancer Metastasis

2015 746 citations Bodu Liu, Lijuan Sun et al. Cancer Cell profile →
CCL18 from Tumor-Associated Macrophages Promotes Breast Cancer Metastasis via PITPNM3

2011 507 citations Yandan Yao, Chang Gong et al. Cancer Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yandan Yao China	37	4.5k	2.3k	1.7k	1.4k	779	77	7.1k
In‐San Kim South Korea	50	4.6k 1.0×	1.5k 0.6×	1.5k 0.9×	1.0k 0.7×	1.2k 1.5×	166	7.7k
Bin Zhang China	43	6.3k 1.4×	3.4k 1.5×	1.4k 0.8×	767 0.6×	392 0.5×	177	9.1k
Philip E. Thorpe United States	51	5.8k 1.3×	2.4k 1.0×	3.5k 2.0×	2.6k 1.8×	593 0.8×	134	10.6k
Reinhard Ebner United States	22	3.5k 0.8×	1.1k 0.5×	1.8k 1.0×	2.1k 1.5×	1.5k 1.9×	27	6.9k
Ralph D. Sanderson United States	64	7.2k 1.6×	2.1k 0.9×	1.1k 0.6×	1.8k 1.3×	236 0.3×	128	11.1k
Hamid Reza Mirzaei Iran	43	2.9k 0.6×	1.8k 0.8×	921 0.5×	1.3k 0.9×	433 0.6×	117	5.0k
Lei Yao China	42	3.2k 0.7×	1.1k 0.5×	1.3k 0.8×	1.6k 1.2×	700 0.9×	151	6.5k
John Hood United States	30	4.2k 0.9×	938 0.4×	648 0.4×	1.1k 0.8×	410 0.5×	56	7.2k
Barbara Fingleton United States	48	5.1k 1.1×	5.1k 2.2×	2.2k 1.3×	5.1k 3.7×	367 0.5×	94	11.7k
Dong‐Er Zhang United States	62	8.0k 1.8×	1.3k 0.6×	5.6k 3.3×	2.5k 1.8×	399 0.5×	173	13.1k

Countries citing papers authored by Yandan Yao

Since Specialization

Citations

This map shows the geographic impact of Yandan Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yandan Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yandan Yao more than expected).

Fields of papers citing papers by Yandan Yao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yandan Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yandan Yao. The network helps show where Yandan Yao may publish in the future.

Co-authorship network of co-authors of Yandan Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Yandan Yao. A scholar is included among the top collaborators of Yandan Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yandan Yao. Yandan Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Jiawei, Zelin Chen, Cong Luo, et al.. (2025). Efficient on-demand cuproptosis induction against triple-negative breast cancer via dual-responsive black phosphorus nanosheet. Materials Today Bio. 33. 101985–101985. 1 indexed citations

Chen, Jiayu, Yuxue Li, Xuefeng He, et al.. (2025). Huaier overcomes tumor-induced immunosuppression in colorectal cancer by activating MHC I and CD8+ T cells. Phytomedicine. 147. 157157–157157.

Ouyang, Qi, Xinyue Xu, Xingxing Wang, et al.. (2025). Extensive cross-reactive T cell epitopes across SARS-CoV-2 Omicron variant spikes with finite immune evasion mutations. Journal of Translational Medicine. 23(1). 1027–1027.

Chen, Keji, Huixia Huang, Zijuan Hu, et al.. (2025). Prognostic and therapeutic implications related to glycosylation profiles of cancer-associated fibroblasts in colorectal cancer: insights from single-cell and bulk transcriptomics. Functional & Integrative Genomics. 25(1). 169–169. 1 indexed citations

Xu, Rui, Weirong Li, Chunhao Lin, et al.. (2023). Repolarization of macrophages to improve sorafenib sensitivity for combination cancer therapy. Acta Biomaterialia. 162. 98–109. 20 indexed citations

Yao, Yandan, et al.. (2023). The Detection of Exosomal PD-L1 in Peripheral Blood. Methods in molecular biology. 2695. 195–212. 4 indexed citations

Yu, Yan, Dongmei Huang, Bo Gao, et al.. (2022). 1017P AdvanTIG-105: Phase Ib dose-expansion study of ociperlimab (OCI) + tislelizumab (TIS) with chemotherapy (chemo) in patients (pts) with metastatic squamous (sq) and non-squamous (non-sq) non-small cell lung cancer (NSCLC). Annals of Oncology. 33. S1019–S1019. 3 indexed citations

Guo, Mingyan, et al.. (2022). Fully Natural Lecithin Encapsulated Nano-Resveratrol for Anti-Cancer Therapy. International Journal of Nanomedicine. Volume 17. 2069–2078. 18 indexed citations

Dong, Zhihui, Senlin Li, Ying Wang, et al.. (2022). Nanoparticles (NPs)-mediated systemic mRNA delivery to reverse trastuzumab resistance for effective breast cancer therapy. Acta Pharmaceutica Sinica B. 13(3). 955–966. 21 indexed citations

10.

Qin, Tao, Zhuofei Bi, Huangming Hong, et al.. (2020). Rac1 activates non-oxidative pentose phosphate pathway to induce chemoresistance of breast cancer. Nature Communications. 11(1). 1456–1456. 137 indexed citations

11.

Nie, Yan, Hongyan Huang, Mingyan Guo, et al.. (2019). Breast Phyllodes Tumors Recruit and Repolarize Tumor-Associated Macrophages via Secreting CCL5 to Promote Malignant Progression, Which Can Be Inhibited by CCR5 Inhibition Therapy. Clinical Cancer Research. 25(13). 3873–3886. 128 indexed citations

12.

Xie, Xiaoying, Nengyong Ouyang, Dongye Wang, et al.. (2018). A case of Cardiobacterium valvarum endocarditis with cerebral hemorrhage after MVR, TVP and vegetation removal operation. Annals of Clinical Microbiology and Antimicrobials. 17(1). 11–11. 5 indexed citations

13.

Nie, Yan, Jianing Chen, Di Huang, et al.. (2017). Tumor-Associated Macrophages Promote Malignant Progression of Breast Phyllodes Tumors by Inducing Myofibroblast Differentiation. Cancer Research. 77(13). 3605–3618. 43 indexed citations

14.

Liu, Bodu, Lijuan Sun, Qiang Liu, et al.. (2015). A Cytoplasmic NF-κB Interacting Long Noncoding RNA Blocks IκB Phosphorylation and Suppresses Breast Cancer Metastasis. Cancer Cell. 27(3). 370–381. 746 indexed citations breakdown →

15.

Gong, Chang, Dong-Young Lee, Hai Hu, et al.. (2014). Prolyl Isomerase Pin1 Acts Downstream of miR200c to Promote Cancer Stem–like Cell Traits in Breast Cancer. Cancer Research. 74(13). 3603–3616. 66 indexed citations

16.

Qian, Pengxu, Zehua Zuo, Zhengsheng Wu, et al.. (2011). Pivotal Role of Reduced let-7g Expression in Breast Cancer Invasion and Metastasis. Cancer Research. 71(20). 6463–6474. 125 indexed citations

17.

Mao, Chengqiong, Jin‐Zhi Du, Tianmeng Sun, et al.. (2011). A biodegradable amphiphilic and cationic triblock copolymer for the delivery of siRNA targeting the acid ceramidase gene for cancer therapy. Biomaterials. 32(11). 3124–3133. 100 indexed citations

18.

Streicher, Katie, Wei Zhu, Kim Lehmann, et al.. (2011). A novel oncogenic role for the miRNA-506-514 cluster in initiating melanocyte transformation and promoting melanoma growth. Oncogene. 31(12). 1558–1570. 110 indexed citations

19.

Chen, Jingqi, Yandan Yao, Fengyan Yu, et al.. (2011). CCL18 from Tumor-Associated Macrophages Promotes Breast Cancer Metastasis via PITPNM3. Cancer Cell. 19(6). 814–816. 18 indexed citations

20.

Li, Jinsong, Hongzhang Huang, Lijuan Sun, et al.. (2009). MiR-21 Indicates Poor Prognosis in Tongue Squamous Cell Carcinomas as an Apoptosis Inhibitor. Clinical Cancer Research. 15(12). 3998–4008. 351 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact